findmyKOL

Liviu Klein, MD

Enriched profile

Professor of Clinical Medicine; Director, Advanced Heart Failure Comprehensive Care Center; Section Chief of Advanced Heart Failure, Mechanical Circulatory Support, Pulmonary Hypertension and Heart Transplant; Director of Cardiology Clinical Research Unit · University of California San Francisco

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 San Francisco, CA · West · United StatesSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusHeart Failure Treatment and Management+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Liviu Klein is Professor of Clinical Medicine; Director, Advanced Heart Failure Comprehensive Care Center; Section Chief of Advanced Heart Failure, Mechanical Circulatory Support, Pulmonary Hypertension and Heart Transplant; Director of Cardiology Clinical Research Unit at University of California San Francisco. OpenAlex indexes 202 publications with 5,905 citations (h-index 37); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.

Data verified 18 Oct 2026

Overview

Updated 21 Oct 2026

Liviu Klein, MD, MS, is Professor of Clinical Medicine at University of California San Francisco. The public record shows 202 publications with 5,905 citations (h-index 37), centered on Heart Failure Treatment and Management, Mechanical Circulatory Support Devices, Cardiovascular Function and Risk Factors. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 16 companies.

  • Most recent indexed publication: 2026 · European heart journal. Acute cardiovascular care
  • Top research focus: Heart Failure Treatment and Management
  • 13 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 16 companies

Generated from the cited public record · current as of 21 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure7 trialsHypertension3 trialsChronic Kidney Disease1 trialVentricular Dysfunction, Right1 trialVentricular Dysfunction1 trial

Research focus

OpenAlex concept fingerprint
Heart Failure Treatment and ManagementMechanical Circulatory Support DevicesCardiovascular Function and Risk FactorsTransplantation: Methods and OutcomesCardiac pacing and defibrillation studies

Drugs & molecules

across trials, industry payments and publications
Jardiancegeneric · EmpagliflozinClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbott LaboratoriesClinical trials—Industry payments210Medtronic, Inc.Clinical trials—Industry payments27Edwards Lifesciences CorporationClinical trials—Industry payments18AbiomedClinical trials—Industry payments15Boston Scientific CorporationClinical trials—Industry payments6CVRx, Inc.Clinical trials—Industry payments3Paragonix Technologies, Inc.Clinical trials—Industry payments3University of California, San FranciscoClinical trials3Industry payments—Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments2Optima Integrated HealthClinical trials2Industry payments—TransMedicsClinical trials2Industry payments—Abbott Medical DevicesClinical trials1Industry payments—Alleviant Medical, Inc.Clinical trials1Industry payments—Ancora Heart, Inc.Clinical trials—Industry payments1AquaPass Medical Ltd.Clinical trials1Industry payments—Axon Therapies, Inc.Clinical trials1Industry payments—Columbia UniversityClinical trials1Industry payments—Cordio MedicalClinical trials1Industry payments—Endotronix, Inc.Clinical trials—Industry payments1Impulse Dynamics (USA) Inc.Clinical trials—Industry payments1Sensible Medical Innovations IncClinical trials—Industry payments1Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments1ZOLL Circulation IncClinical trials—Industry payments1ZOLL Medical CorporationClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
202publications

Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.

5,905citations

Total citations across indexed works.

37h-index

Hirsch index (OpenAlex). i10-index 78.

Clinical & industry

trials, payments and federal funding
13clinical trials

Investigator role on registered studies.

View trials ↓
16companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 21 Oct 2026

Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 21 Oct 2026

16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    55.3%
    Beta blocker8.6%
    Bisoprolol Fumarate39%Metoprolol Succinate27%Carvedilol22%Sotalol13%
    Part D<11 patients
    Aldosterone antagonist (MRA)8.1%
    Spironolactone89%Eplerenone11%
    Part D<11 patients

    + 12 more classes in this area

  • Metabolism & gastrointestinal

    18.3%
    SGLT2 inhibitor10%
    Jardiance83%Farxiga17%
    Part D<11 patients
    Proton pump inhibitor6.9%
    Pantoprazole Sodium39%Lansoprazole34%Omeprazole27%
    Part D≥13 patients

    + 1 more class in this area

  • Blood & clotting

    8.6%
    Vitamin K antagonist4.6%
    Warfarin Sodium100%
    Part D≥21 patients
    Factor Xa inhibitor1.2%
    Eliquis100%
    Part D<11 patients

    + 3 more classes in this area

All 9 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)85.1% facility · 14.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 21 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 21 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Omer T. Inan24Charles B. Eaton22Teresa De Marco19JoAnn E. Manson18Mihai Gheorghiade18Mozziyar Etemadi17Van N. Selby14Michael S. Kiernan14Lisa Warsinger Martin13Kathleen L. Grady12James Alex Heller12Barbara V. Howard10C S Lee10Georg Maximilian Wieselthaler10Michael J. LaMonte10Colleen Kelley McIlvennan10Khadijah K Breathett10Mary Norine Walsh10Bernice Ruo10Josef Stehlik10Munir Janmohamed10Quin E. Denfeld10Larry A. Allen10David G. Beiser9Matthew Allison9Shuvo Roy9JoAnn M. Lindenfeld9Yasuhiro Shudo9Jana Svetlichnaya9Elizabeth A. Hahn9Jonathan D. Rich8David F Cella8F. Esmailian8Marat Fudim8Lucian Lozonschi8Jeffrey J. Teuteberg8Duc Thinh Pham8Mandar A. Aras8Nisha I. Parikh7Donald M. Lloyd‐Jones7

Background & recognition

Updated 21 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certification

    American Board of Internal Medicine - Advanced Heart Failure & Transplantation

    2012
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
  • Board Certification

    American Board of Internal Medicine - Cardiovascular Disease

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsf.edu ↗
  • MD

    Carol Davila School of Medicine

    1999
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsf.edu ↗

Editorial & leadership roles

journal and society appointments
  • Faculty Member

    Board Certification Review Faculty

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗

Awards & honors

honors on the public record

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.